186 related articles for article (PubMed ID: 16398741)
1. A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium.
Ivanovic Z; Duchez P; Dazey B; Hermitte F; Lamrissi-Garcia I; Mazurier F; Praloran V; Reiffers J; Vezon G; Boiron JM
Transfusion; 2006 Jan; 46(1):126-31. PubMed ID: 16398741
[TBL] [Abstract][Full Text] [Related]
2. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
[TBL] [Abstract][Full Text] [Related]
3. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
Andrews RG; Briddell RA; Hill R; Gough M; McNiece IK
Stem Cells; 1999; 17(4):210-8. PubMed ID: 10437984
[TBL] [Abstract][Full Text] [Related]
4. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
Li K; Li CK; Chuen CK; Tsang KS; Fok TF; James AE; Lee SM; Shing MM; Chik KW; Yuen PM
Eur J Haematol; 2005 Feb; 74(2):128-35. PubMed ID: 15654904
[TBL] [Abstract][Full Text] [Related]
5. The potential role of FLT3 ligand in progenitor and primitive hematopoietic cell expansion.
Poloni A; Douay L; Giarratana MC; Kobari L; Gorin NC; Olivieri A; Leoni P
Boll Soc Ital Biol Sper; 1997; 73(3-4):55-62. PubMed ID: 9540233
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin to replace megakaryocyte-derived growth factor: impact on stem and progenitor cells during ex vivo expansion of CD34+ cells mobilized in peripheral blood.
Duchez P; Chevaleyre J; Vlaski M; Dazey B; Bijou F; Lafarge X; Milpied N; Boiron JM; Ivanovic Z
Transfusion; 2011 Feb; 51(2):313-8. PubMed ID: 20735764
[TBL] [Abstract][Full Text] [Related]
7. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.
Levac K; Karanu F; Bhatia M
Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567
[TBL] [Abstract][Full Text] [Related]
8. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
9. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells.
Madkaikar M; Ghosh K; Gupta M; Swaminathan S; Mohanty D
Acta Haematol; 2007; 118(3):153-9. PubMed ID: 17890847
[TBL] [Abstract][Full Text] [Related]
11. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
[TBL] [Abstract][Full Text] [Related]
12. Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 days.
de Kreuk AM; Jonkhoff AR; Zevenbergen A; Hendriks EC; Schuurhuis GJ; Ossenkoppele GJ; Dräger AM; van Oostveen JW; Huijgens PC
Bone Marrow Transplant; 2001 Jul; 28(2):145-55. PubMed ID: 11509932
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of stem cells: defining optimum conditions using various cytokines.
Mohamed AA; Ibrahim AM; El-Masry MW; Mansour IM; Khroshied MA; Gouda HM; Riad RM
Lab Hematol; 2006; 12(2):86-93. PubMed ID: 16751136
[TBL] [Abstract][Full Text] [Related]
14. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
[TBL] [Abstract][Full Text] [Related]
15. Serum-free culture conditions for cells capable of producing long-term survival in lethally irradiated mice.
Brown RL; Xu FS; Dusing SK; Li Q; Fischer R; Patchen M
Stem Cells; 1997; 15(3):237-45. PubMed ID: 9170216
[TBL] [Abstract][Full Text] [Related]
16. Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study.
Berger M; Fagioli F; Piacibello W; Sanavio F; Mareschi K; Biasin E; Bruno S; Gammaitoni L; Gunetti M; Nesi F; Madon E; Aglietta M
Bone Marrow Transplant; 2002 Mar; 29(5):443-8. PubMed ID: 11919735
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue.
Zimmerman TM; Lee WJ; Bender JG; Schilling M; Smith SL; Van Epps DE; Williams SF
Bone Marrow Transplant; 2000 Sep; 26(5):505-10. PubMed ID: 11019839
[TBL] [Abstract][Full Text] [Related]
18. Clinical-scale cultures of cord blood CD34(+) cells to amplify committed progenitors and maintain stem cell activity.
Ivanovic Z; Duchez P; Chevaleyre J; Vlaski M; Lafarge X; Dazey B; Robert-Richard E; Mazurier F; Boiron JM
Cell Transplant; 2011; 20(9):1453-63. PubMed ID: 21294956
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells.
Yao M; Fouillard L; Lemoine FM; Bouchet S; Firat H; Andreu G; Gorin NC; Douay L; Lopez M
Bone Marrow Transplant; 2000 Sep; 26(5):497-503. PubMed ID: 11019838
[TBL] [Abstract][Full Text] [Related]
20. Cell culture bags allow a large extent of ex vivo expansion of LTC-IC and functional mature cells which can subsequently be frozen: interest for a large-scale clinical applications.
Giarratana MC; Kobari L; Neildez Nguyen TM; Firat H; Bouchet S; Lopez M; Gorin NC; Thierry D; Douay L
Bone Marrow Transplant; 1998 Oct; 22(7):707-15. PubMed ID: 9818701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
